| HOME >> BIOLOGY >> TECHNOLOGY |
ST. LOUIS, Dec. 30, 2010 /PRNewswire-FirstCall/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced today it has acquired all outstanding shares of Cerilliant Corporation of Round Rock, Texas to strengthen the Company's analytical chemistry product portfolio and to continue to deliver on its strategic growth plans. Cerilliant, a leading supplier of high quality reference standards and materials, provides products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets. Terms of the purchase were not disclosed. The Company expects this acquisition to be neutral to mildly accretive to earnings per share in 2011. Cerilliant has been a portfolio company of Argenta Partners of Dallas, Texas for the past 10 years.
Cerilliant brings to Sigma-Aldrich over 2,800 products and more than 30 years of expertise in the design, development, synthesis, characterization and packaging of analytical standards, calibrators, controls and certified reference materials that are used in a wide range of analytical applications. The standards company is well known for its visionary approach to serving these growing industries with a continually expanding line of innovative new products and sustains a modern, robust quality system which incorporates cGMP, GLP and ISO requirements. Cerilliant is accredited to ISO Guide 34, ISO/IEC 17025 and is certified to ISO 9001:2008. Its extensive capabilities complement Sigma-Aldrich's existing Fluka® and Supelco® analytical brands and will expand the Company's analytical customer base and markets. Cerilliant employs 65 people at its state-of-the-art laboratory and manufacturing facility in Round Rock, Texas. Its website can be accessed at www.cerilliant.com.
"Cerilliant's strong product suite and solid relationships with cus
'/>"/>
| SOURCE Sigma-Aldrich Corporation Copyright©2010 PR Newswire. All rights reserved |